So can you share a word about how you make it and which was the results of this pricing strategy?

Yeah.

And again, I think when we thought about going to paint companies, broadly defined, we did not want to walk in there with a monomer.

And again, that's kind of a resin precursor in layman's terms.

But we didn't want to say, hey, we've got this cool little molecule.

What do you think? What we really wanted to do and what we did in-house was develop formulation expertise.

And I'll tell you, you work with a lot of partners and you're a paint formulation expert.

So can you tell us more about that moment in your journey as a CEO and how you developed the narrative for the acquisition?